Document Detail


Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia.
MedLine Citation:
PMID:  10426644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare the angiotensinogen genotypes in normotensive and pre-eclamptic pregnancies in maternal and fetal samples. DESIGN: Prospective observational study. SETTING: University Hospital, Queen's Medical Centre, Nottingham. POPULATION: Forty-three women with pre-eclampsia and 84 normotensive pregnant women. Fetal samples were available for genotyping from 96% of the pregnancies. METHODS: Maternal and fetal DNA was genotyped at angiotensinogen codon 235 and at a dinucleotide repeat polymorphism in the 3' flanking region of the gene. Angiotensinogen and renin concentrations were measured in maternal plasma by radioimmunoassay. RESULTS: In contrast to earlier studies, no association was demonstrated between the angiotensinogen 235 Thr variant and pre-eclampsia. Normotensive pregnant women homozygous for this variant had significantly lower plasma angiotensinogen concentrations (median 2.2 ng AI/mL; IQR 1.8-3.0) than women homozygous for the 235 Met allele (3.6 ng AI/mL; IQR 2.5-4.1; P = 0.04). In pre-eclamptic pregnancies, 79% (11/14) of mothers heterozygous for the dinucleotide repeat allele designated A9 transmitted this allele to the fetus, more frequently than would be expected by chance (P = 0.02). The A9 allele was associated with low plasma angiotensinogen concentrations (P = 0.001) and high renin concentrations (P = 0.02) in normotensive women. CONCLUSIONS: There is no evidence that the angiotensinogen 235 Thr allele is associated with pre-eclampsia in the Nottingham population. The angiotensinogen 235 Thr allele is associated with low plasma angiotensinogen concentrations in normotensive pregnant women, in contrast to the high levels associated with this variant in non-pregnant women, suggesting that regulation of angiotensinogen expression in normal pregnancy may differ significantly from that in the non-pregnant state. There is preliminary evidence that maternal-fetal transmission of an angiotensinogen allele associated with low plasma angiotensinogen concentrations is associated with pre-eclampsia. Impaired generation of angiotensin II at the maternal-fetal interface may be a factor in the pathogenesis of pre-eclampsia.
Authors:
L Morgan; S Crawshaw; P N Baker; F Broughton Pipkin; N Kalsheker
Related Documents :
18991324 - Prediction of pre-eclampsia by a combination of maternal history, uterine artery dopple...
3237484 - Could oedema and proteinuria in pregnancy be used to screen for high risk? the who inte...
9736084 - Minimally invasive bedside craniotomy using a self-controlling pre-adjustable mechanica...
18190374 - Maternal cardiac function and uterine artery doppler at 11-14 weeks in the prediction o...
22223754 - Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with...
19142904 - Second trimester prenatal ultrasound for the detection of pregnancies at increased risk...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of obstetrics and gynaecology     Volume:  106     ISSN:  0306-5456     ISO Abbreviation:  Br J Obstet Gynaecol     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-08-11     Completed Date:  1999-08-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7503752     Medline TA:  Br J Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  244-51     Citation Subset:  AIM; IM    
Affiliation:
Department of Clinical Laboratory Sciences, University Hospital, Nottingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alleles
Angiotensinogen / blood,  genetics*
Female
Fetal Blood / metabolism*
Genotype
Humans
Polymorphism, Genetic
Pre-Eclampsia / blood,  genetics*
Pregnancy
Prospective Studies
Renin / blood
Chemical
Reg. No./Substance:
11002-13-4/Angiotensinogen; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of tocolytic treatment with ritodrine on cardiovascular autonomic regulation.
Next Document:  Epidemiological characteristics of women with high grade CIN who do and do not have human papillomav...